B61 FUNCTION DURING VASCULAR DEVELOPMENT
B61 在血管发育过程中的功能
基本信息
- 批准号:6139265
- 负责人:
- 金额:$ 10.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-10 至 2001-12-31
- 项目状态:已结题
- 来源:
- 关键词:angiogenesis biological signal transduction carcinogenesis cell differentiation embryo /fetus embryonic stem cell gene expression gene mutation gene targeting genetic mapping genetically modified animals immunocytochemistry laboratory mouse ligands mammalian embryology protein tyrosine kinase tissue /cell culture vascular endothelium
项目摘要
DESCRIPTION (Adapted from Investigator's Abstract): Progressive growth of
tumors is dependent on continuous stimulation of new blood vessel formation.
Considerable evidence indicates that receptor-protein tyrosine kinases
(R-PTKs) and their ligands have crucial roles in the differentiation of
endothelial cells and their subsequent organization into the vascular
system. "Knockout mice" carrying mutations in endothelial cell specific
R-PTKs and ligands, such as flk-1, flk-1, tie-2, and VEGF, result in
embryonic lethality due to aberrant vascular development. Interestingly,
mutation in each gene gives rise to distinct phenotypic abnormalities.
These data indicate that multiple signaling pathways, each with
nonoverlapping functions, are required for elaboration of the endocardium
and vasculature. It will be essential to identify and characterize other
loci that contribute to endothelial cell development in order to define the
multiple pathways required for vasculogenesis and angiogenesis. B61, the
major ligand for the ECK R-PTK (B61 also binds other members of the eph
family), was shown by others to possess angiogenic and endothelial cell
attractant activity. Consistent with this notion, B61 is expressed at
sites of blood vessel formation during mouse embryogenesis. These data
raise the intriguing possibility that B61 has a major role in recruiting
endothelial cells into the developing vasculature. To test this hypothesis,
first, candidate receptors for the B61 ligand will be identified by
screening each member of the eph family for expression in the developing
mouse vascular system by whole mount immunohistochemistry. Second, gene
targeting in embryonic stem cells will be used to generate mice that carry
null mutations at the B61 locus. Homozygous mutant embryos will be analyzed
for defects in endothelial cell and blood vessel development. The extent of
vascular development in mutant embryos will be assessed by histological
analysis and by examination of the expression of three genes, flk-1, flt-1
and tek , that are markers for early to late stages of endothelial cell
differentiation. Third, to assess the role of B61 and eck in tumor
angiogenesis, embryonic stem cell lines that carry double knockouts at the
B61 and/or eck loci (i.e., B61-1- and/or eck-1 cell lines) will be used to
generate teratocarcinomas in syngeneic or immunocompromised mice. Tumors
will be examined after four weeks for extent of tumor growth and vascular
development. It is anticipated that these data will provide insight into
the function of the B61/ECK signaling pathway in vascular development during
embryogenesis and tumorigenesis.
描述(改编自研究者摘要):
肿瘤依赖于新血管形成的持续刺激。
大量证据表明受体蛋白酪氨酸激酶
(R-PTKs)及其配体在肿瘤细胞分化中起着至关重要的作用。
内皮细胞及其随后组织成血管
系统 “敲除小鼠”携带内皮细胞特异性
R-PTK和配体,如flk-1、flk-1、tie-2和VEGF,导致
由于异常的血管发育导致的胚胎死亡。 有趣的是,
每个基因的突变引起不同的表型异常。
这些数据表明,多种信号通路,每一个与
不重叠的职能,需要详细说明内
和脉管系统。 必须确定和描述其他
基因座,有助于内皮细胞的发展,以确定
血管生成和血管生成所需的多种途径。 B61,
ECK R-PTK的主要配体(B61也结合Eph的其它成员
家族),被其他人证明具有血管生成和内皮细胞
引诱活性 与此概念一致,B61表示为
小鼠胚胎发育过程中血管形成的部位。 这些数据
提出了一种有趣的可能性,即B61在招募方面发挥了重要作用,
内皮细胞进入发育中的脉管系统。 为了验证这个假设,
首先,将通过以下方法鉴定B61配体的候选受体:
筛选Eph家族的每个成员在发育中的细胞中的表达,
小鼠血管系统整体包埋免疫组化。 第二,基因
胚胎干细胞中的靶向将用于产生携带
B61位点的无效突变。 将分析纯合突变胚胎
用于内皮细胞和血管发育缺陷。 的程度
将通过组织学方法评估突变胚胎中的血管发育。
分析并通过检测flk-1、flt-1
和TEK,它们是内皮细胞早期到晚期的标志物,
分化 第三,探讨B61和eck在肿瘤中的作用
血管生成,胚胎干细胞系,携带双敲除在
B61和/或eck基因座(即,B61-1-和/或eck-1细胞系)将用于
在同基因或免疫缺陷小鼠中产生畸胎瘤。 肿瘤
四周后将检查肿瘤生长和血管的程度。
发展 预计这些数据将提供深入了解
B61/ECK信号通路在血管发育中的作用
胚胎发生和肿瘤发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH C. RUIZ其他文献
JOSEPH C. RUIZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH C. RUIZ', 18)}}的其他基金
Development of allele-specific protein-based therapeutic targeting the pathogenic RNA associated with Spinocerebellar ataxia type 3
开发基于等位基因特异性蛋白的疗法,靶向与 3 型脊髓小脑共济失调相关的致病性 RNA
- 批准号:
10552829 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
Protein-based Therapeutics to treat nucleotide expansion disorders associated with aberrant gene expression
基于蛋白质的疗法,用于治疗与异常基因表达相关的核苷酸扩增疾病
- 批准号:
10086917 - 财政年份:2020
- 资助金额:
$ 10.45万 - 项目类别:
Ablation of the pathogenic RNA transcript associated with myotonic dystrophy, DM1
与强直性肌营养不良 (DM1) 相关的致病性 RNA 转录物的消融
- 批准号:
9919285 - 财政年份:2019
- 资助金额:
$ 10.45万 - 项目类别:
Novel SCID rat models for human cell transplantation studies
用于人类细胞移植研究的新型 SCID 大鼠模型
- 批准号:
7926058 - 财政年份:2010
- 资助金额:
$ 10.45万 - 项目类别:
Tissue-Specific Mutagenesis in Rat as an In Vivo Tool for Colon Cancer Gene Disco
大鼠组织特异性诱变作为结肠癌的体内工具 Gene Disco
- 批准号:
7630038 - 财政年份:2009
- 资助金额:
$ 10.45万 - 项目类别:
Clearing intrahepatic lipids to aid in toxicity testing
清除肝内脂质以帮助毒性测试
- 批准号:
7537640 - 财政年份:2008
- 资助金额:
$ 10.45万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 10.45万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 10.45万 - 项目类别: